Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice

Journal of Nutritional Biochemistry

Volumn 22, Issue 5, 2011, Pages 459-469

  Halade, Ganesh V ^a   Rahman, Md M ^a   Williams, Paul J ^a   Fernandes, Gabriel ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bone adiposity; Conjugated linoleic acid; Fat mass; Fish oil; Obesity

Indexed keywords

CATHEPSIN K; CONJUGATED LINOLEIC ACID; FISH OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE DENSITY; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FATTY LIVER; FEMALE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIVER HYPERTROPHY; MOUSE; NONHUMAN; OBESITY; OSTEOLYSIS; OSTEOPOROSIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; WEIGHT REDUCTION;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADIPOSITY; AGING; ANIMALS; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; BONE MARROW; CORN OIL; DIET; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FATTY LIVER; FEMALE; FISH OILS; INSULIN RESISTANCE; LINOLEIC ACIDS, CONJUGATED; MICE; MICE, INBRED C57BL; OSTEOPOROSIS; PPAR GAMMA;

MUS; ZEA MAYS;

EID: 79954571944     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.03.015     Document Type: Article

References (57)

1. Di Iorgi N., Rosol M., Mittelman S.D., Gilsanz V. Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults. J Clin Endocrinol Metab 2008, 93:2281-2286.
2. Zhao L.J., Jiang H., Papasian C.J., et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 2008, 23:17-29.
3. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
4. Belury M.A. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 2002, 22:505-531.
5. Bhattacharya A., Banu J., Rahman M., Causey J., Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 2006, 17:789-810.
6. Ruxton C.H., Reed S.C., Simpson M.J., Millington K.J. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 2004, 17:449-459.
7. Sun D., Krishnan A., Zaman K., Lawrence R., Bhattacharya A., Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003, 18:1206-1216.
8. Yaqoob P., Calder P.C. N-3 polyunsaturated fatty acids and inflammation in the arterial wall. Eur J Med Res 2003, 8:337-354.
9. Mori T.A., Bao D.Q., Burke V., Puddey I.B., Beilin L.J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999, 34:253-260.
10. Montori V.M., Farmer A., Wollan P.C., Dinneen S.F. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 2000, 23:1407-1415.
11. 2008. http://www.foodnavigator-usa.com/Legislation/CLA-achieves-US-approval-for-use-in-foods.
12. Whigham L.D., Watras A.C., Schoeller D.A. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr 2007, 85:1203-1211.
13. Rahman M.M., Bhattacharya A., Banu J., Fernandes G. Conjugated linoleic acid protects against age-associated bone loss in C57BL/6 female mice. J Nutr Biochem 2007, 18:467-474.
14. Tsuboyama-Kasaoka N., Takahashi M., Tanemura K., et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 2000, 49:1534-1542.
15. Moloney F., Yeow T.P., Mullen A., Nolan J.J., Roche H.M. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with Type 2 diabetes mellitus. Am J Clin Nutr 2004, 80:887-895.
16. Riserus U., Vessby B., Arner P., Zethelius B. Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 2004, 47:1016-1019.
17. Riserus U., Arner P., Brismar K., Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002, 25:1516-1521.
18. DeLany J.P., Blohm F., Truett A.A., Scimeca J.A., West D.B. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol 1999, 276:R1172-1179.
19. Poirier H., Niot I., Clement L., Guerre-Millo M., Besnard P. Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse. Biochimie 2005, 87:73-79.
20. Halade G.V., Rahman M.M., Fernandes G. Effect of CLA isomers and their mixture on aging C57Bl/6J mice. Eur J Nutr 2009, 48:409-418.
21. Noto A., Zahradka P., Yurkova N., et al. Conjugated linoleic acid reduces hepatic steatosis, improves liver function, and favorably modifies lipid metabolism in obese insulin-resistant rats. Lipids 2006, 41:179-188.
22. Neschen S., Morino K., Dong J, et al. n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner. Diabetes 2007, 56:1034-1041.
23. Storlien L.H., Kraegen E.W., Chisholm D.J., Ford G.L., Bruce D.G., Pascoe W.S. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987, 237:885-888.
24. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
25. Halade GV, Rahman MM, Williams PJ, Fernandes G. High fat diet-induced animal model of age-associated obesity and osteoporosis. J Nutr Biochem [in press].
26. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., Feinglos M.N., Diet-induced type I.I. diabetes in C57BL/6J mice. Diabetes 1988, 37:1163-1167.
27. Glatt V., Canalis E., Stadmeyer L., Bouxsein M.L. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 2007, 22:1197-1207.
28. Nagy T.R., Clair A.L. Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes Res 2000, 8:392-398.
29. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997, 46:3-10.
30. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
31. Chen J.L., Hunt P., McElvain M., Black T., Kaufman S., Choi E.S. Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells 1997, 15:368-377.
32. Yang H., Youm Y.H., Dixit V.D. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J Immunol 2009, 183:3040-3052.
33. Ozgocmen S., Kaya H., Fadillioglu E., Aydogan R., Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 2007, 295:45-52.
34. Garrett I.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990, 85:632-639.
35. Cheleuitte D., Mizuno S., Glowacki J. In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status. J Clin Endocrinol Metab 1998, 83:2043-2051.
36. Watras A.C., Buchholz A.C., Close R.N., Zhang Z., Schoeller D.A. The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. Int J Obes (Lond) 2007, 31:481-487.
37. Sevastianos V.A., Hadziyannis S.J. Nonalcoholic fatty liver disease: from clinical recognition to treatment. Expert Rev Gastroenterol Hepatol 2008, 2:59-79.
38. Degrace P., Demizieux L., Gresti J., Chardigny J.M., Sebedio J.L., Clouet P. Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10,cis-12-isomer of linoleic acid. J Nutr 2004, 134:861-867.
39. Koda M., Kawakami M., Murawaki Y., Senda M. The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies. J Gastroenterol 2007, 42:897-903.
40. Warren J.M., Simon V.A., Bartolini G., Erickson K.L., Mackey B.E., Kelley D.S. Trans-10,cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes. Lipids 2003, 38:497-504.
41. Riserus U., Smedman A., Basu S., Vessby B. Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am J Clin Nutr 2004, 79:1146S-1148S.
42. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
43. Sanyal A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002, 123:1705-1725.
44. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008, 9:367-377.
45. Flachs P., Mohamed-Ali V., Horakova O., et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 2006, 49:394-397.
46. Duda M.K., O'Shea K.M., Lei B., et al. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 2007, 76:303-310.
47. Martin P.G., Guillou H., Lasserre F., et al. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study. Hepatology 2007, 45:767-777.
48. Yamamoto K., Itoh T., Abe D., et al. Identification of putative metabolites of docosahexaenoic acid as potent PPARgamma agonists and antidiabetic agents. Bioorg Med Chem Lett 2005, 15:517-522.
49. Naveiras O., Nardi V., Wenzel P.L., Hauschka P.V., Fahey F., Daley G.Q. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009, 460:259-263.
50. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83:461S-465S.
51. Rahman M.M., Bhattacharya A., Banu J., Kang J.X., Fernandes G. Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis. J Cell Mol Med 2009.
52. Bhattacharya A., Rahman M., Sun D., Fernandes G. Effect of fish oil on bone mineral density in aging C57BL/6 female mice. J Nutr Biochem 2007, 18:372-379.
53. Saftig P., Hunziker E., Wehmeyer O., et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci U S A 1998, 95:13453-13458.
54. Sheweita S.A., Khoshhal K.I. Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. Curr Drug Metab 2007, 8:519-525.
55. Kelley D.S., Vemuri M., Adkins Y., Gill S.H., Fedor D., Mackey B.E. Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice. Br J Nutr 2009, 101:701-708.
56. Sneddon A.A., Tsofliou F., Fyfe C.L., et al. Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin. Obesity (Silver Spring) 2008, 16:1019-1024.
57. Ide T. Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes 2005, 54:412-423.